Cellbxhealth PLC
ANPCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 30.9% | 110% | 2.8% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 62.2% | -18.7% | 58.9% | 70.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -455.1% | -869.1% | -2,342.7% | -1,551.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -497% | -921% | -2,083.2% | -1,481.9% |
| EPS Diluted | -0.048 | -0.077 | -0.088 | -0.067 |
| % Growth | 37.6% | 12.1% | -31.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |